About
Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides.
Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides…click to learn more.
Management Team…click to learn more.
Board of Directors…click to learn more.
Helix BioMedix has assembled a strong team of leading dermatologists, peptide specialists, and pharmaceutical researchers to provide scientific support to our programs…click to learn more.
Helix BioMedix, Inc has partnered with leading fine ingredient suppliers and manufacturers to market our peptides in the consumer segment…click to learn more.
Information on Helix BioMedix

What We Do

Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our common stock trade over-the-counter under the symbol “HXBM.OB”. We have developed a proprietary library containing a broad and diverse array of bioactive peptides. Our patent estate covers six distinct classes of peptides, comprising more than 100,000 unique peptide sequences. Our primary commercial objective is to out-license proprietary peptides to entities that possess sales, marketing and/or manufacturing expertise. Our peptides appear to have both pharmaceutical as well as non-pharmaceutical uses including broad-spectrum topical anti-infectives, wound healing agents, and cosmeceutical peptide ingredients.